Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients

27 Jan 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35083501
DOI: 10.1007/s00280-021-04389-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patientsPMID 35083501Read ↗

The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomesSemantic proximity Read ↗

Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.Semantic proximity Read ↗

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantationSemantic proximity Read ↗

Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipientsSemantic proximity Read ↗

Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.Semantic proximity Read ↗

CYP2B6 genetic variation in cyclophosphamide metabolism and hemorrhagic cystitis in Fanconi anemia patients undergoing allogeneic hematopoietic cell transplantationSemantic proximity Read ↗

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelinesSemantic proximity Read ↗

Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Genetic basis of clinical variants of chemotherapy toxicity in children with acute lymphoblastic leukemia (literature review)Semantic proximity Read ↗

Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation Survival.Semantic proximity Read ↗

Genetic factors influence the development of acute graft-versus-host disease in adults undergoing allogeneic bone marrow transplantation.Semantic proximity Read ↗

Influence of Genetic Variation of GST, CYP, and ABC on the Safety and Efficacy of Cyclophosphamide-Based Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.